Lite Strategy Becomes First US Public Company to Adopt Litecoin as Primary Reserve Asset

Lite Strategy, Inc. (NASDAQ: LITS), previously known as MEI Pharma, has announced its first quarter fiscal year 2026 results, emphasizing the successful implementation of a $100 million Litecoin treasury strategy. The company has acquired 929,548 LTC tokens, positioning itself as the first U.S.-listed public entity to adopt Litecoin as a primary reserve asset.

This initiative began with a $100 million PIPE offering in July 2025, marking a shift in corporate strategy towards digital assets. Lite Strategy has entered a strategic partnership with GSR, a prominent crypto investment firm, to oversee treasury management and ensure robust governance. Key appointments include Charlie Lee, creator of Litecoin, and Joshua Riezman of GSR to the board of directors.

The company rebranded from MEI Pharma to Lite Strategy, updating its NASDAQ ticker from MEIP to LITS and launching a new website. In October, Lite Strategy unveiled a $25 million share repurchase program, transitioning from initial Litecoin accumulation to active capital market operations. As of September 30, 2025, the firm reported $12.21 million in working capital with no debt, underscoring its financial stability.